Is It Possible to Differentiate the Impact of Pediatric Monophasic Demyelinating Disorders and Multiple Sclerosis After a First Episode of Demyelination?

被引:0
|
作者
Aubert-Broche, Berengere [1 ]
Fonov, Vladimir [1 ]
Weier, Katrin [1 ]
Narayanan, Sridar [1 ]
Arnold, Douglas L. [1 ]
Banwell, Brenda [2 ,3 ]
Collins, D. Louis [1 ]
机构
[1] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada
[2] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[3] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
关键词
MRI; ATROPHY; AGE;
D O I
10.1007/978-3-319-14905-9_4
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
A first episode of acute demyelination of the central nervous system may be a monophasic transient illness or represent the first attack of multiple sclerosis (MS). This study investigates if it is possible to distinguish these two groups of patients retrospectively at the time of the first episode, in a pediatric population. For each patient, the method consists in fitting an individual brain growth curve using multiple follow-up time-points, and using this curve to predict 4 metrics at the first attack: brain volume, brain growth rate, thalamus volume normalized by the brain volume (called normalized thalamus) and normalized thalamus growth rate. These metrics were compared to age-and-sex matched healthy controls by computing z-scores. In this study, 85 patients were scanned up to 8 years after the first attack. During this follow-up period, 23 patients were subsequently diagnosed with MS (MS group). Among the 62 patients with a transient illness, 9 suffered from monophasic acute disseminated encephalomyelitis (ADEM group). The 53 remaining formed the non-ADEM monophasic (MONO) group. The normalized thalamus growth rate was the only metric that distinguished patient groups: the z-scores were significantly smaller for MS than for the MONO group (p<0.01). Whereas 93% of monophasic subjects were correctly classified with a linear discriminant analysis, only 13% of the MS subjects were correctly classified, due to a large inter-individual variability in this group.
引用
收藏
页码:38 / 48
页数:11
相关论文
共 50 条
  • [41] Prognostic relevance of antimyelin antibodies for progression to multiple sclerosis after a first demyelinating event:: results from the BENEFIT study
    Kuhle, J.
    Kappos, L.
    Pohl, C.
    Mehling, M.
    Edan, G.
    Freedman, M.
    Hartung, H. -P.
    Miller, D. H.
    Montalban, X.
    Polman, C.
    Barkhof, F.
    Bauer, L.
    Dahms, S.
    Lindberg, R. L. P.
    Sandbrink, R.
    MULTIPLE SCLEROSIS, 2006, 12 : S17 - S17
  • [42] Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis
    Gaetani, Lorenzo
    Eusebi, Paolo
    Mancini, Andrea
    Gentili, Lucia
    Borrelli, Angela
    Parnetti, Lucilla
    Calabresi, Paolo
    Sarchielli, Paola
    Blennow, Kaj
    Zetterberg, Henrik
    Di Filippo, Massimiliano
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 35 : 228 - 232
  • [43] Asymptomatic bradycardia after first fingolimod dose in a pediatric patient with multiple sclerosis – a case report
    Martina Petruzzo
    Roberta Lanzillo
    Neurological Sciences, 2021, 42 : 37 - 39
  • [44] Asymptomatic bradycardia after first fingolimod dose in a pediatric patient with multiple sclerosis - a case report
    Petruzzo, Martina
    Lanzillo, Roberta
    NEUROLOGICAL SCIENCES, 2021, 42 (SUPPL 1) : 37 - 39
  • [45] Magnetic resonance imaging at first episode in pediatric multiple sclerosis retrospective evaluation according to KIDMUS and lesion dissemination in space criteria
    Kurne, Asli
    Oguz, Kader K.
    Aksu, Aysegul Oz
    Yarar, Coskun
    Duman, Oezgur
    Kurul, Semra Hiz
    Serdaroglu, Ayse
    Anlar, Banu
    BRAIN & DEVELOPMENT, 2010, 32 (06): : 487 - 494
  • [46] Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
    Monschein, Tobias
    Salhofer-Polanyi, Sabine
    Altmann, Patrick
    Zrzavy, Tobias
    Dal-Bianco, Assunta
    Bsteh, Gabriel
    Rommer, Paulus
    Berger, Thomas
    Leutmezer, Fritz
    JOURNAL OF NEUROLOGY, 2021, 268 (04) : 1247 - 1253
  • [47] Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis
    Tur, Carmen
    Carbonell-Mirabent, Pere
    Cobo-Calvo, Alvaro
    Otero-Romero, Susana
    Arrambide, Georgina
    Midaglia, Luciana
    Castillo, Joaquin
    Vidal-Jordana, Angela
    Rodriguez-Acevedo, Breogan
    Zabalza, Ana
    Galan, Ingrid
    Nos, Carlos
    Salerno, Annalaura
    Auger, Cristina
    Pareto, Deborah
    Comabella, Manuel
    Rio, Jordi
    Sastre-Garriga, Jaume
    Rovira, Alex
    Tintore, Mar
    Montalban, Xavier
    JAMA NEUROLOGY, 2023, 80 (02) : 151 - 160
  • [48] One-year risk of multiple sclerosis after a first episode of optic neuritis according to modern diagnosis criteria
    Lebranchu, Pierre
    Mazhar, Driss
    Wiertlewski, Sandrine
    Le Meur, Guylene
    Couturier, Justine
    Ducloyer, Jean-Baptiste
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 93
  • [49] Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
    Tobias Monschein
    Sabine Salhofer-Polanyi
    Patrick Altmann
    Tobias Zrzavy
    Assunta Dal-Bianco
    Gabriel Bsteh
    Paulus Rommer
    Thomas Berger
    Fritz Leutmezer
    Journal of Neurology, 2021, 268 : 1247 - 1253
  • [50] Recovery of pediatric patients after first multiple sclerosis relapse is associated with suppression of antigen presenting mechanism
    Gurevich, M.
    Khavkin, Y.
    Menascu, S.
    Zilkha-Falb, R.
    Achiron, A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 596 - 597